2024 International Cancer Immunotherapy Conference (CICON24)

The Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI) are proud to present the Eighth International Cancer lmmunotherapy Conference.

The 2024 meeting will be held September 8-11, 2024 in National Harbor, MD. The program will focus on “Translating Science into Survival,” and feature talks from more than 60 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy.

Conference Co-Chairpersons

Elizabeth M. Jaffee, Johns Hopkins, Baltimore, MD
Guido Kroemer, Gustave Roussy Cancer Center, Villejuif, France
Dana Pe’er, Memorial Sloan Kettering Cancer Center, New York, NY
Özlem Türeci, BioNTech, Mainz, Germany

Committee Members

James P. Allison, University of Texas M.D. Anderson Cancer Center, Houston, TX
Tullia Bruno, University of Pittsburgh, Pittsburgh, PA
Giulia Casorati, IRCCS Ospedale San Raffaele, Milan, Italy
Yvonne Chen, UCLA, Los Angeles, CA
Lisa Derosa, Gustave Roussy Cancer Center, Villejuif, France
Mustafa Diken, TRON-Translational Oncology, Mainz, Germany
Wolf Hervé Fridman, Cordeliers Research Center, Paris, France
Ming Li, Memorial Sloan Kettering Cancer, New York, NY
Johanna Olweus, Oslo University Hospital, Oslo, Norway
Ellen Puré, University of Pennsylvania, Philadelphia, PA
Antonio Sica, IRCCS Humanitas Clinical and Research Centre, Rozzano, Milan, Italy
Gregory Sonnenberg, Weill Cornell Cancer Center, New York, NY

Learn More:

Register